[A10-01] Biologic medications as second-line therapy for rheumatoid arthritis

Last updated 26.08.2013

Project no.:
A10-01

Commission:
Commission awarded on 20.05.2010 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Muscles, bones and joints

26.08.2013

Rheumatoid arthritis: biologics in second-line therapy show benefit

Positive effects for all drugs / long-term data and robust direct comparisons are lacking

Current document

Accompanying information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealth.org.

Contact

Info Service

Subscribe to daily updated information on projects, calls for tender, and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.